Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thorotrast associated hepatic angiosarcoma with 36 years latency.

J C Underwood, P Huck

    Cancer
    |December 1, 1978
    PubMed
    Summary

    This case study details a rare hepatic angiosarcoma that appeared 36 years after Thorotrast administration. The unusually long latent period between exposure and cancer development is highlighted.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Erratum: Observation of D^{0} Meson Nuclear Modifications in Au+Au Collisions at sqrt[s_{NN}]=200  GeV [Phys. Rev. Lett. 113, 142301 (2014)].

    Physical review letters·2018
    Same author

    Dijet imbalance measurements in Au+Au and pp collisions at sqrt[s_{NN}]=200  GeV at STAR.

    Physical review letters·2017
    Same author

    Charge-Dependent Directed Flow in Cu+Au Collisions at sqrt[s_{NN}]=200  GeV.

    Physical review letters·2017
    Same author

    Measurement of the Transverse Single-Spin Asymmetry in p^{↑}+p→W^{±}/Z^{0} at RHIC.

    Physical review letters·2016
    Same author

    Beam Energy Dependence of the Third Harmonic of Azimuthal Correlations in Au+Au Collisions at RHIC.

    Physical review letters·2016
    Same author

    Centrality and Transverse Momentum Dependence of Elliptic Flow of Multistrange Hadrons and ϕ Meson in Au+Au Collisions at √[sNN]=200  GeV.

    Physical review letters·2016

    Area of Science:

    • Radiology
    • Oncology
    • Toxicology

    Background:

    • Thorotrast, a radioactive contrast agent, was historically used for diagnostic imaging.
    • Long-term health risks associated with Thorotrast exposure include various cancers.

    Observation:

    • A patient developed hepatic angiosarcoma (liver cancer).
    • The cancer manifested 36 years after the patient received Thorotrast.
    • Radiological and autoradiographic findings were analyzed.

    Findings:

    • The case presents an exceptionally long latent period for Thorotrast-induced cancer.
    • Hepatic angiosarcoma is a rare but serious potential outcome of Thorotrast exposure.

    Implications:

    • This case underscores the persistent risk of delayed cancer development from historical radioactive agents.
    • Highlights the importance of long-term patient follow-up after exposure to diagnostic radioactive materials.
    • Contributes to understanding the carcinogenicity and latency of Thorotrast.

    Related Experiment Videos